BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 30524447)

  • 1. TCR Repertoire as a Novel Indicator for Immune Monitoring and Prognosis Assessment of Patients With Cervical Cancer.
    Cui JH; Lin KR; Yuan SH; Jin YB; Chen XP; Su XK; Jiang J; Pan YM; Mao SL; Mao XF; Luo W
    Front Immunol; 2018; 9():2729. PubMed ID: 30524447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and prognostic significance of profiling the peripheral blood T-cell receptor repertoire in patients with advanced lung cancer.
    Liu YY; Yang QF; Yang JS; Cao RB; Liang JY; Liu YT; Zeng YL; Chen S; Xia XF; Zhang K; Liu L
    Int J Cancer; 2019 Sep; 145(5):1423-1431. PubMed ID: 30664810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Different T-cell Receptor Repertoires in Breast Cancer Tumors, Draining Lymph Nodes, and Adjacent Tissues.
    Wang T; Wang C; Wu J; He C; Zhang W; Liu J; Zhang R; Lv Y; Li Y; Zeng X; Cao H; Zhang X; Xu X; Huang C; Wang L; Liu X
    Cancer Immunol Res; 2017 Feb; 5(2):148-156. PubMed ID: 28039161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune repertoire: A potential biomarker and therapeutic for hepatocellular carcinoma.
    Han Y; Li H; Guan Y; Huang J
    Cancer Lett; 2016 Sep; 379(2):206-12. PubMed ID: 26188280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput sequencing of CD4
    Wang L; Zhang P; Li J; Lu H; Peng L; Ling J; Zhang X; Zeng X; Zhao Y; Zhang W
    Arthritis Res Ther; 2019 Dec; 21(1):295. PubMed ID: 31856905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell receptor diversity as a prognostic biomarker in melanoma patients.
    Charles J; Mouret S; Challende I; Leccia MT; De Fraipont F; Perez S; Plantier N; Plumas J; Manuel M; Chaperot L; Aspord C
    Pigment Cell Melanoma Res; 2020 Jul; 33(4):612-624. PubMed ID: 31971658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood T-cell receptor repertoire as a predictor of clinical outcomes in gastrointestinal cancer patients treated with PD-1 inhibitor.
    Ji S; Li J; Chang L; Zhao C; Jia R; Tan Z; Liu R; Zhang Y; Li Y; Yin G; Guan Y; Xia X; Yi X; Xu J
    Clin Transl Oncol; 2021 Aug; 23(8):1646-1656. PubMed ID: 33583004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical T Cell Receptor Repertoire Deep Sequencing and Analysis: An Application to Monitor Immune Reconstitution Following Cord Blood Transplantation.
    Gkazi AS; Margetts BK; Attenborough T; Mhaldien L; Standing JF; Oakes T; Heather JM; Booth J; Pasquet M; Chiesa R; Veys P; Klein N; Chain B; Callard R; Adams SP
    Front Immunol; 2018; 9():2547. PubMed ID: 30455696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the diversity of T cell receptor γδ complementary determinant region 3 in human peripheral blood by Immune Repertoire Sequencing.
    Chen H; Zou M; Teng D; Zhang J; He W
    J Immunol Methods; 2017 Apr; 443():9-17. PubMed ID: 28159550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal High-Throughput Sequencing of the T-Cell Receptor Repertoire Reveals Dynamic Change and Prognostic Significance of Peripheral Blood TCR Diversity in Metastatic Colorectal Cancer During Chemotherapy.
    Chen YT; Hsu HC; Lee YS; Liu H; Tan BC; Chin CY; Chang IY; Yang CY
    Front Immunol; 2021; 12():743448. PubMed ID: 35095836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive investigation of T and B cell receptor repertoires in an MC38 tumor model following murine anti‑PD‑1 administration.
    Zhang L; Wang IM; Solban N; Cristescu R; Zeng G; Long B
    Mol Med Rep; 2020 Aug; 22(2):975-985. PubMed ID: 32468004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-driven T-cell selection in patients with cervical cancer as evidenced by T-cell receptor analysis and recognition of autologous tumor.
    Pilch H; Höhn H; Neukirch C; Freitag K; Knapstein PG; Tanner B; Maeurer MJ
    Clin Diagn Lab Immunol; 2002 Mar; 9(2):267-78. PubMed ID: 11874862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating CD8
    Lin KR; Pang DM; Jin YB; Hu Q; Pan YM; Cui JH; Chen XP; Lin YX; Mao XF; Duan HB; Luo W
    Cancer Immunol Immunother; 2018 Nov; 67(11):1743-1752. PubMed ID: 30167861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell receptor repertoire profiling predicts the prognosis of HBV-associated hepatocellular carcinoma.
    Lin KR; Deng FW; Jin YB; Chen XP; Pan YM; Cui JH; You ZX; Chen HW; Luo W
    Cancer Med; 2018 Aug; 7(8):3755-3762. PubMed ID: 29947152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-Generation Sequencing Analysis of the Human TCRγδ+ T-Cell Repertoire Reveals Shifts in Vγ- and Vδ-Usage in Memory Populations upon Aging.
    Kallemeijn MJ; Kavelaars FG; van der Klift MY; Wolvers-Tettero ILM; Valk PJM; van Dongen JJM; Langerak AW
    Front Immunol; 2018; 9():448. PubMed ID: 29559980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T Cell Receptor Beta-Chain Profiling of Tumor Tissue, Peripheral Blood and Regional Lymph Nodes From Patients With Papillary Thyroid Carcinoma.
    Wang Y; Liu Y; Chen L; Chen Z; Wang X; Jiang R; Zhao K; He X
    Front Immunol; 2021; 12():595355. PubMed ID: 33679738
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of the Repertoire Features of TCR Beta Chain CDR3 in Human by High-Throughput Sequencing.
    Hou X; Wang M; Lu C; Xie Q; Cui G; Chen J; Du Y; Dai Y; Diao H
    Cell Physiol Biochem; 2016; 39(2):651-67. PubMed ID: 27442436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [T cell repertoires correlate with pathogenesis of chronic idiopathic thrombocytopenic purpura].
    Zhu X; Zhu P; Guo XL
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3316-22. PubMed ID: 16409835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of T cell receptor repertoire in penile cancer.
    Zhang J; Wang Y; Huang Y; Tan X; Xu J; Yan Q; Tan J; Zhang Y; Zhang J; Ma Q; Zhu H; Ye J; Zhu Z; Lan W
    Cancer Immunol Immunother; 2024 Jan; 73(2):24. PubMed ID: 38280010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCR meta-clonotypes for biomarker discovery with
    Mayer-Blackwell K; Schattgen S; Cohen-Lavi L; Crawford JC; Souquette A; Gaevert JA; Hertz T; Thomas PG; Bradley P; Fiore-Gartland A
    Elife; 2021 Nov; 10():. PubMed ID: 34845983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.